| Tariq Ali Khan Md | |
|
14642 Newport Ave Suite 408 Tustin CA 92780-6057 | |
| (657) 218-9859 | |
| (657) 218-4023 |
| Full Name | Tariq Ali Khan Md |
|---|---|
| Speciality | Internal Medicine |
| Location | 14642 Newport Ave, Tustin, California |
| Authorized Official Name and Position | Tariq Ali Khan (OWNER) |
| Authorized Official Contact | 6572189859 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tariq Ali Khan Md 14642 Newport Ave Suite 408 Tustin CA 92780-6057 Ph: (657) 218-9859 | Tariq Ali Khan Md 14642 Newport Ave Suite 408 Tustin CA 92780-6057 Ph: (657) 218-9859 |
| NPI Number | 1033662101 |
|---|---|
| Provider Enumeration Date | 07/25/2016 |
| Last Update Date | 02/23/2017 |
| Medicare PECOS PAC ID | 8022385418 |
|---|---|
| Medicare Enrollment ID | O20170607000648 |
News Archive
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Stem cell therapies are often limited by low survival of transplanted stem cells and the lack of precise control over their differentiation into the terminal cell types needed to repair or replace injured tissues. Now, a team led by Wyss Institute Core Faculty member David Mooney, Ph.D., has developed a new strategy - embedding stem cells into porous, transplantable hydrogels - that has experimentally improved bone repair by boosting the survival rate of transplanted stem cells and influencing their cell differentiation.
Karl Deisseroth of Stanford University, Gero Miesenb-ck of the University of Oxford and Edward S. Boyden of the Massachusetts Institute of Technology have been awarded Brandeis University's 16th Annual Jacob Heskel Gabbay Award in Biotechnology and Medicine.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
In a study of 552 adults aged 70 to 93 years old, 80% of participants had at least one skin disease that required treatment, and the most common conditions were fungal skin infections, rosacea, actinic keratosis, and eczema. ?
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033662101 | NPI | - | NPPES |
| 1295925253 | Other | CA | NPI INDIVIDUAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A112661 (California) | Primary |
| Provider Name | Tariq Ali Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295925253 PECOS PAC ID: 0143397190 Enrollment ID: I20110926000255 |
News Archive
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Stem cell therapies are often limited by low survival of transplanted stem cells and the lack of precise control over their differentiation into the terminal cell types needed to repair or replace injured tissues. Now, a team led by Wyss Institute Core Faculty member David Mooney, Ph.D., has developed a new strategy - embedding stem cells into porous, transplantable hydrogels - that has experimentally improved bone repair by boosting the survival rate of transplanted stem cells and influencing their cell differentiation.
Karl Deisseroth of Stanford University, Gero Miesenb-ck of the University of Oxford and Edward S. Boyden of the Massachusetts Institute of Technology have been awarded Brandeis University's 16th Annual Jacob Heskel Gabbay Award in Biotechnology and Medicine.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
In a study of 552 adults aged 70 to 93 years old, 80% of participants had at least one skin disease that required treatment, and the most common conditions were fungal skin infections, rosacea, actinic keratosis, and eczema. ?
› Verified 7 days ago
News Archive
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Stem cell therapies are often limited by low survival of transplanted stem cells and the lack of precise control over their differentiation into the terminal cell types needed to repair or replace injured tissues. Now, a team led by Wyss Institute Core Faculty member David Mooney, Ph.D., has developed a new strategy - embedding stem cells into porous, transplantable hydrogels - that has experimentally improved bone repair by boosting the survival rate of transplanted stem cells and influencing their cell differentiation.
Karl Deisseroth of Stanford University, Gero Miesenb-ck of the University of Oxford and Edward S. Boyden of the Massachusetts Institute of Technology have been awarded Brandeis University's 16th Annual Jacob Heskel Gabbay Award in Biotechnology and Medicine.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
In a study of 552 adults aged 70 to 93 years old, 80% of participants had at least one skin disease that required treatment, and the most common conditions were fungal skin infections, rosacea, actinic keratosis, and eczema. ?
› Verified 7 days ago
Families Together Of Orange County Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 661 W 1st St Ste G, Tustin, CA 92780 Phone: 714-665-9890 | |
Redhill Medical Center Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1442 Irvine Blvd Ste 101, Tustin, CA 92780 Phone: 714-544-5007 | |
Prospice Medical Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14742 Newport Avenue, Suite 203, Tustin, CA 92780 Phone: 949-825-6416 Fax: 951-537-6931 | |
Lin Wu Dba Oc Health Acupuncture Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 740 El Camino Real, Suite 100, Tustin, CA 92780 Phone: 949-228-8028 Fax: 949-438-0559 | |
Charles Kim Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14642 Newport Ave Ste 105, Tustin, CA 92780 Phone: 951-801-5566 Fax: 714-486-2309 | |
Assist Medical Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1431 Warner Ave Ste A, Tustin, CA 92780 Phone: 509-945-9977 Fax: 509-873-0049 |